LFB awards Therapure plasma protein contract

- Last updated on GMT

LFB Biomedicaments has awarded Thrapure Biopharma a protein manufacturing contract that will see the Canadian CDMO install new production capacity at its facility in Toronto.

Under the contract, France-based LFB will retrofit Therapure’s facility with the specialist technology required to extract proteins from human plasma and hopes to obtain full regulatory approval during 2013.

LFB CEO Christian Bechon explained that the contract development and manufacturing organisation (CDMO) will play an important role in the expansion of his firm’s business in North America.

The news follows just days after Therapure completed the installation of commercial-scale lyophilisation capacity at its plant​ Mississauga in Ontario.

Related topics: Contract Manufacturing, Bulk ingredients

Related news

Show more

Related suppliers